International Stem Cell Corporation (ISCO)
Develops stem cell therapies for brain diseases and sells lab cells for medical research.
$0.28+0.06%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+75.0%
The outlook
ISCO trades at $0.28, positioned well above both its 50- and 200-day moving averages. The stock sits near the upper end of its 52-week range, roughly 80% of the way from its low to high. Analyst coverage appears thin on this micro-cap biotech name.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range80% of the way from its 52-week low to high
Market cap
$2.2M
52-wk high
$0.32
52-wk low
$0.12
50-day avg
$0.18
200-day avg
$0.16
Trailing P/E
—